Gaemers I C, van Pelt A M, van der Saag P T, Hoogerbrugge J W, Themmen A P, de Rooij D G
Department of Cell Biology, Utrecht University Medical School, The Netherlands.
Endocrinology. 1997 Apr;138(4):1544-51. doi: 10.1210/endo.138.4.5051.
The testicular gene expression of the retinoic acid receptors, RAR alpha, -beta, and -gamma, was studied in normal mice and in vitamin A-deficient mice after the administration of all-trans-retinoic acid (ATRA). All three types of RARs were expressed in normal and/or vitamin A-deficient testes. Only the expression of RAR beta messenger RNA was transiently induced within 24 h after ATRA injection. ATRA-induced RAR beta expression was also found in purified Sertoli cells, suggesting that these cells mediate at least part of the effect of retinoids on germ cells. When an equimolar amount of retinol was administered instead of ATRA, no induction of RAR beta was seen at the point of maximal induction by ATRA, suggesting that the effect of retinol was delayed and probably less. The related nuclear receptors, RXR alpha, -beta, and, for the first time, gamma, were also shown to be present in the mouse testis. Upon administration of ATRA, messenger RNA expression of RXR alpha and -beta did not change significantly. The expression of RXR gamma was too low to allow quantification. Finally, the effect of the retinoid metabolism inhibitor liarozole on ATRA-induced proliferation of A spermatogonia was examined. The labeling index of A spermatogonia, 24 h after the administration of 0.25 mg ATRA, was significantly lowered by liarozole due to a shift of the maximal 5-bromo-deoxyuridine incorporation to an earlier point (20 h). This indicates that liarozole delays retinoid metabolism, thereby increasing the actual ATRA concentration, and more importantly, that ATRA by itself is an active retinoid in spermatogenesis. Apparently, ATRA does not need to be metabolized to 4-oxo-RA, which was previously shown to be a more potent inducer of spermatogonial proliferation than ATRA, to be effective.
研究了全反式维甲酸(ATRA)给药后正常小鼠和维生素A缺乏小鼠睾丸中维甲酸受体RARα、-β和-γ的基因表达。所有三种类型的RAR在正常和/或维生素A缺乏的睾丸中均有表达。仅RARβ信使核糖核酸的表达在ATRA注射后24小时内被短暂诱导。在纯化的支持细胞中也发现了ATRA诱导的RARβ表达,这表明这些细胞至少介导了类视黄醇对生殖细胞的部分作用。当给予等摩尔量的视黄醇而非ATRA时,在ATRA最大诱导点未见RARβ的诱导,这表明视黄醇的作用延迟且可能较弱。相关的核受体RXRα、-β以及首次发现的γ也在小鼠睾丸中被证实存在。给予ATRA后,RXRα和-β的信使核糖核酸表达没有显著变化。RXRγ的表达过低无法进行定量。最后,研究了类视黄醇代谢抑制剂莱洛唑对ATRA诱导的A型精原细胞增殖的影响。给予0.25mg ATRA后24小时,莱洛唑使A型精原细胞的标记指数显著降低,原因是最大5-溴脱氧尿苷掺入时间提前至20小时。这表明莱洛唑延迟了类视黄醇代谢,从而提高了实际的ATRA浓度,更重要的是,表明ATRA本身在精子发生中是一种活性类视黄醇。显然,ATRA不需要代谢为4-氧代视黄酸(先前已证明其比ATRA更有效地诱导精原细胞增殖)就能发挥作用。